30 June 2020>: Clinical Research
Application of the Molecular Adsorbent Recirculating System in Type 1 Hepatorenal Syndrome in the Course of Alcohol-Related Acute on Chronic Liver Failure
Grzegorz Kade 1ABCEF , Arkadiusz Lubas 1ACDEF , Sebastian Spaleniak 2ADEF* , Anna Wojtecka 1B , Ksymena Leśniak 1B , Sławomir Literacki 3BF , Stanisław Niemczyk 1E , Przemysław Dyrla 4BCDEDOI: 10.12659/MSM.923805
Med Sci Monit 2020; 26:e923805
Table 4 Comparison of blood pressure and laboratory data before and after MARS treatment.
Variable | Before MARS | After MARS | ||
---|---|---|---|---|
Mean | SD | Mean | SD | |
Bilirubin (mg/dL) | 27.5 | 6.1 | 22.3 | 4.0 |
Ammonia (μmol/L) | 44.1 | 22.5 | 27.6 | 20.9 |
Creatinine (mg/dL) | 1.5 | 1.0 | 1.1 | 0.6 |
Urea (mg/dL) | 83.8 | 36.1 | 72.1 | 33.3 |
SBP (mmHg) | 114.2 | 13.1 | 117.9 | 14.4 |
DBP (mmHg) | 70.6 | 10.9 | 73.6 | 9.8 |
HR (bpm) | 82.7 | 14.0 | 82.5 | 11.6 |
MARS – Molecular Adsorbent Recirculating System; SBP – systolic blood pressure; DBP – diastolic blood pressure; MAP – mean arterial blood pressure; HR – heart rate; bpm – beats per minute; SD – standard deviation. |